Kindred Biosciences, Inc. (KIN) Expanded Agreement with Vaxart To Gear Up Manufacturing Of COVID-19 and Other Vaccine Candidates
Kindred Biosciences, Inc. (KIN) this week came expanding an agreement with Vaxart, Inc. for the manufacturing of Vaxart’s oral vaccine for COVID-19 as well as other vaccine candidates. The biopharmaceutical company developing novel biologics will be performing manufacturing services through its wholly owned subsidiary Centaur Biopharmaceutical Services (Centaur), which is a provider of full service contract development […]
